Osteoarthritis Pain Market Report

Global Osteoarthritis Pain Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Feb 25, 2022
  • PAGES：148
  • REPORT CODE：GMM773719
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Osteoarthritis Pain market report explains the definition, types, applications, major countries, and major players of the Osteoarthritis Pain market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Abbott Laboratories

    • Novartis International

    • Afferent Pharmaceuticals

    • BioDelivery Sciences International

    • AbbVie

    • Pfizer

    • Crystal Genomics

    • Cytori Therapeutics

    • Johnson & Johnson

    • Abiogen Pharma

    • Astellas Pharma

    By Type:

    • Oral

    • Non-Oral

    By End-User:

    • Hospital

    • Pharmacy

    • Other

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Osteoarthritis Pain Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Osteoarthritis Pain Outlook to 2028- Original Forecasts

    • 2.2 Osteoarthritis Pain Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Osteoarthritis Pain Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Osteoarthritis Pain Market- Recent Developments

    • 6.1 Osteoarthritis Pain Market News and Developments

    • 6.2 Osteoarthritis Pain Market Deals Landscape

    7 Osteoarthritis Pain Raw Materials and Cost Structure Analysis

    • 7.1 Osteoarthritis Pain Key Raw Materials

    • 7.2 Osteoarthritis Pain Price Trend of Key Raw Materials

    • 7.3 Osteoarthritis Pain Key Suppliers of Raw Materials

    • 7.4 Osteoarthritis Pain Market Concentration Rate of Raw Materials

    • 7.5 Osteoarthritis Pain Cost Structure Analysis

      • 7.5.1 Osteoarthritis Pain Raw Materials Analysis

      • 7.5.2 Osteoarthritis Pain Labor Cost Analysis

      • 7.5.3 Osteoarthritis Pain Manufacturing Expenses Analysis

    8 Global Osteoarthritis Pain Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Osteoarthritis Pain Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Osteoarthritis Pain Export by Region (Top 10 Countries) (2017-2028)

    9 Global Osteoarthritis Pain Market Outlook by Types and Applications to 2022

    • 9.1 Global Osteoarthritis Pain Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Oral Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Non-Oral Consumption and Growth Rate (2017-2022)

    • 9.2 Global Osteoarthritis Pain Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Pharmacy Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Other Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Osteoarthritis Pain Market Analysis and Outlook till 2022

    • 10.1 Global Osteoarthritis Pain Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Osteoarthritis Pain Consumption (2017-2022)

      • 10.2.2 Canada Osteoarthritis Pain Consumption (2017-2022)

      • 10.2.3 Mexico Osteoarthritis Pain Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Osteoarthritis Pain Consumption (2017-2022)

      • 10.3.2 UK Osteoarthritis Pain Consumption (2017-2022)

      • 10.3.3 Spain Osteoarthritis Pain Consumption (2017-2022)

      • 10.3.4 Belgium Osteoarthritis Pain Consumption (2017-2022)

      • 10.3.5 France Osteoarthritis Pain Consumption (2017-2022)

      • 10.3.6 Italy Osteoarthritis Pain Consumption (2017-2022)

      • 10.3.7 Denmark Osteoarthritis Pain Consumption (2017-2022)

      • 10.3.8 Finland Osteoarthritis Pain Consumption (2017-2022)

      • 10.3.9 Norway Osteoarthritis Pain Consumption (2017-2022)

      • 10.3.10 Sweden Osteoarthritis Pain Consumption (2017-2022)

      • 10.3.11 Poland Osteoarthritis Pain Consumption (2017-2022)

      • 10.3.12 Russia Osteoarthritis Pain Consumption (2017-2022)

      • 10.3.13 Turkey Osteoarthritis Pain Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Osteoarthritis Pain Consumption (2017-2022)

      • 10.4.2 Japan Osteoarthritis Pain Consumption (2017-2022)

      • 10.4.3 India Osteoarthritis Pain Consumption (2017-2022)

      • 10.4.4 South Korea Osteoarthritis Pain Consumption (2017-2022)

      • 10.4.5 Pakistan Osteoarthritis Pain Consumption (2017-2022)

      • 10.4.6 Bangladesh Osteoarthritis Pain Consumption (2017-2022)

      • 10.4.7 Indonesia Osteoarthritis Pain Consumption (2017-2022)

      • 10.4.8 Thailand Osteoarthritis Pain Consumption (2017-2022)

      • 10.4.9 Singapore Osteoarthritis Pain Consumption (2017-2022)

      • 10.4.10 Malaysia Osteoarthritis Pain Consumption (2017-2022)

      • 10.4.11 Philippines Osteoarthritis Pain Consumption (2017-2022)

      • 10.4.12 Vietnam Osteoarthritis Pain Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Osteoarthritis Pain Consumption (2017-2022)

      • 10.5.2 Colombia Osteoarthritis Pain Consumption (2017-2022)

      • 10.5.3 Chile Osteoarthritis Pain Consumption (2017-2022)

      • 10.5.4 Argentina Osteoarthritis Pain Consumption (2017-2022)

      • 10.5.5 Venezuela Osteoarthritis Pain Consumption (2017-2022)

      • 10.5.6 Peru Osteoarthritis Pain Consumption (2017-2022)

      • 10.5.7 Puerto Rico Osteoarthritis Pain Consumption (2017-2022)

      • 10.5.8 Ecuador Osteoarthritis Pain Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Osteoarthritis Pain Consumption (2017-2022)

      • 10.6.2 Kuwait Osteoarthritis Pain Consumption (2017-2022)

      • 10.6.3 Oman Osteoarthritis Pain Consumption (2017-2022)

      • 10.6.4 Qatar Osteoarthritis Pain Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Osteoarthritis Pain Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Osteoarthritis Pain Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Osteoarthritis Pain Consumption (2017-2022)

      • 10.7.2 South Africa Osteoarthritis Pain Consumption (2017-2022)

      • 10.7.3 Egypt Osteoarthritis Pain Consumption (2017-2022)

      • 10.7.4 Algeria Osteoarthritis Pain Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Osteoarthritis Pain Consumption (2017-2022)

      • 10.8.2 New Zealand Osteoarthritis Pain Consumption (2017-2022)

    11 Global Osteoarthritis Pain Competitive Analysis

    • 11.1 Abbott Laboratories

      • 11.1.1 Abbott Laboratories Company Details

      • 11.1.2 Abbott Laboratories Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Abbott Laboratories Osteoarthritis Pain Main Business and Markets Served

      • 11.1.4 Abbott Laboratories Osteoarthritis Pain Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Novartis International

      • 11.2.1 Novartis International Company Details

      • 11.2.2 Novartis International Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Novartis International Osteoarthritis Pain Main Business and Markets Served

      • 11.2.4 Novartis International Osteoarthritis Pain Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Afferent Pharmaceuticals

      • 11.3.1 Afferent Pharmaceuticals Company Details

      • 11.3.2 Afferent Pharmaceuticals Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Afferent Pharmaceuticals Osteoarthritis Pain Main Business and Markets Served

      • 11.3.4 Afferent Pharmaceuticals Osteoarthritis Pain Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 BioDelivery Sciences International

      • 11.4.1 BioDelivery Sciences International Company Details

      • 11.4.2 BioDelivery Sciences International Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 BioDelivery Sciences International Osteoarthritis Pain Main Business and Markets Served

      • 11.4.4 BioDelivery Sciences International Osteoarthritis Pain Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 AbbVie

      • 11.5.1 AbbVie Company Details

      • 11.5.2 AbbVie Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 AbbVie Osteoarthritis Pain Main Business and Markets Served

      • 11.5.4 AbbVie Osteoarthritis Pain Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Pfizer

      • 11.6.1 Pfizer Company Details

      • 11.6.2 Pfizer Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Pfizer Osteoarthritis Pain Main Business and Markets Served

      • 11.6.4 Pfizer Osteoarthritis Pain Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Crystal Genomics

      • 11.7.1 Crystal Genomics Company Details

      • 11.7.2 Crystal Genomics Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Crystal Genomics Osteoarthritis Pain Main Business and Markets Served

      • 11.7.4 Crystal Genomics Osteoarthritis Pain Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Cytori Therapeutics

      • 11.8.1 Cytori Therapeutics Company Details

      • 11.8.2 Cytori Therapeutics Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Cytori Therapeutics Osteoarthritis Pain Main Business and Markets Served

      • 11.8.4 Cytori Therapeutics Osteoarthritis Pain Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Johnson & Johnson

      • 11.9.1 Johnson & Johnson Company Details

      • 11.9.2 Johnson & Johnson Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Johnson & Johnson Osteoarthritis Pain Main Business and Markets Served

      • 11.9.4 Johnson & Johnson Osteoarthritis Pain Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Abiogen Pharma

      • 11.10.1 Abiogen Pharma Company Details

      • 11.10.2 Abiogen Pharma Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Abiogen Pharma Osteoarthritis Pain Main Business and Markets Served

      • 11.10.4 Abiogen Pharma Osteoarthritis Pain Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 Astellas Pharma

      • 11.11.1 Astellas Pharma Company Details

      • 11.11.2 Astellas Pharma Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 Astellas Pharma Osteoarthritis Pain Main Business and Markets Served

      • 11.11.4 Astellas Pharma Osteoarthritis Pain Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    12 Global Osteoarthritis Pain Market Outlook by Types and Applications to 2028

    • 12.1 Global Osteoarthritis Pain Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Oral Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Non-Oral Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Osteoarthritis Pain Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Pharmacy Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Osteoarthritis Pain Market Analysis and Outlook to 2028

    • 13.1 Global Osteoarthritis Pain Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Osteoarthritis Pain Consumption Forecast (2022-2028)

      • 13.2.2 Canada Osteoarthritis Pain Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Osteoarthritis Pain Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Osteoarthritis Pain Consumption Forecast (2022-2028)

      • 13.3.2 UK Osteoarthritis Pain Consumption Forecast (2022-2028)

      • 13.3.3 Spain Osteoarthritis Pain Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Osteoarthritis Pain Consumption Forecast (2022-2028)

      • 13.3.5 France Osteoarthritis Pain Consumption Forecast (2022-2028)

      • 13.3.6 Italy Osteoarthritis Pain Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Osteoarthritis Pain Consumption Forecast (2022-2028)

      • 13.3.8 Finland Osteoarthritis Pain Consumption Forecast (2022-2028)

      • 13.3.9 Norway Osteoarthritis Pain Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Osteoarthritis Pain Consumption Forecast (2022-2028)

      • 13.3.11 Poland Osteoarthritis Pain Consumption Forecast (2022-2028)

      • 13.3.12 Russia Osteoarthritis Pain Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Osteoarthritis Pain Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Osteoarthritis Pain Consumption Forecast (2022-2028)

      • 13.4.2 Japan Osteoarthritis Pain Consumption Forecast (2022-2028)

      • 13.4.3 India Osteoarthritis Pain Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Osteoarthritis Pain Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Osteoarthritis Pain Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Osteoarthritis Pain Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Osteoarthritis Pain Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Osteoarthritis Pain Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Osteoarthritis Pain Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Osteoarthritis Pain Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Osteoarthritis Pain Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Osteoarthritis Pain Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Osteoarthritis Pain Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Osteoarthritis Pain Consumption Forecast (2022-2028)

      • 13.5.3 Chile Osteoarthritis Pain Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Osteoarthritis Pain Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Osteoarthritis Pain Consumption Forecast (2022-2028)

      • 13.5.6 Peru Osteoarthritis Pain Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Osteoarthritis Pain Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Osteoarthritis Pain Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Osteoarthritis Pain Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Osteoarthritis Pain Consumption Forecast (2022-2028)

      • 13.6.3 Oman Osteoarthritis Pain Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Osteoarthritis Pain Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Osteoarthritis Pain Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Osteoarthritis Pain Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Osteoarthritis Pain Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Osteoarthritis Pain Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Osteoarthritis Pain Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Osteoarthritis Pain Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Osteoarthritis Pain Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Osteoarthritis Pain Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Osteoarthritis Pain

    • Figure of Osteoarthritis Pain Picture

    • Table Global Osteoarthritis Pain Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Osteoarthritis Pain Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Oral Consumption and Growth Rate (2017-2022)

    • Figure Global Non-Oral Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Pharmacy Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Osteoarthritis Pain Consumption by Country (2017-2022)

    • Table North America Osteoarthritis Pain Consumption by Country (2017-2022)

    • Figure United States Osteoarthritis Pain Consumption and Growth Rate (2017-2022)

    • Figure Canada Osteoarthritis Pain Consumption and Growth Rate (2017-2022)

    • Figure Mexico Osteoarthritis Pain Consumption and Growth Rate (2017-2022)

    • Table Europe Osteoarthritis Pain Consumption by Country (2017-2022)

    • Figure Germany Osteoarthritis Pain Consumption and Growth Rate (2017-2022)

    • Figure UK Osteoarthritis Pain Consumption and Growth Rate (2017-2022)

    • Figure Spain Osteoarthritis Pain Consumption and Growth Rate (2017-2022)

    • Figure Belgium Osteoarthritis Pain Consumption and Growth Rate (2017-2022)

    • Figure France Osteoarthritis Pain Consumption and Growth Rate (2017-2022)

    • Figure Italy Osteoarthritis Pain Consumption and Growth Rate (2017-2022)

    • Figure Denmark Osteoarthritis Pain Consumption and Growth Rate (2017-2022)

    • Figure Finland Osteoarthritis Pain Consumption and Growth Rate (2017-2022)

    • Figure Norway Osteoarthritis Pain Consumption and Growth Rate (2017-2022)

    • Figure Sweden Osteoarthritis Pain Consumption and Growth Rate (2017-2022)

    • Figure Poland Osteoarthritis Pain Consumption and Growth Rate (2017-2022)

    • Figure Russia Osteoarthritis Pain Consumption and Growth Rate (2017-2022)

    • Figure Turkey Osteoarthritis Pain Consumption and Growth Rate (2017-2022)

    • Table APAC Osteoarthritis Pain Consumption by Country (2017-2022)

    • Figure China Osteoarthritis Pain Consumption and Growth Rate (2017-2022)

    • Figure Japan Osteoarthritis Pain Consumption and Growth Rate (2017-2022)

    • Figure India Osteoarthritis Pain Consumption and Growth Rate (2017-2022)

    • Figure South Korea Osteoarthritis Pain Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Osteoarthritis Pain Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Osteoarthritis Pain Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Osteoarthritis Pain Consumption and Growth Rate (2017-2022)

    • Figure Thailand Osteoarthritis Pain Consumption and Growth Rate (2017-2022)

    • Figure Singapore Osteoarthritis Pain Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Osteoarthritis Pain Consumption and Growth Rate (2017-2022)

    • Figure Philippines Osteoarthritis Pain Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Osteoarthritis Pain Consumption and Growth Rate (2017-2022)

    • Table South America Osteoarthritis Pain Consumption by Country (2017-2022)

    • Figure Brazil Osteoarthritis Pain Consumption and Growth Rate (2017-2022)

    • Figure Colombia Osteoarthritis Pain Consumption and Growth Rate (2017-2022)

    • Figure Chile Osteoarthritis Pain Consumption and Growth Rate (2017-2022)

    • Figure Argentina Osteoarthritis Pain Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Osteoarthritis Pain Consumption and Growth Rate (2017-2022)

    • Figure Peru Osteoarthritis Pain Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Osteoarthritis Pain Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Osteoarthritis Pain Consumption and Growth Rate (2017-2022)

    • Table GCC Osteoarthritis Pain Consumption by Country (2017-2022)

    • Figure Bahrain Osteoarthritis Pain Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Osteoarthritis Pain Consumption and Growth Rate (2017-2022)

    • Figure Oman Osteoarthritis Pain Consumption and Growth Rate (2017-2022)

    • Figure Qatar Osteoarthritis Pain Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Osteoarthritis Pain Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Osteoarthritis Pain Consumption and Growth Rate (2017-2022)

    • Table Africa Osteoarthritis Pain Consumption by Country (2017-2022)

    • Figure Nigeria Osteoarthritis Pain Consumption and Growth Rate (2017-2022)

    • Figure South Africa Osteoarthritis Pain Consumption and Growth Rate (2017-2022)

    • Figure Egypt Osteoarthritis Pain Consumption and Growth Rate (2017-2022)

    • Figure Algeria Osteoarthritis Pain Consumption and Growth Rate (2017-2022)

    • Table Oceania Osteoarthritis Pain Consumption by Country (2017-2022)

    • Figure Australia Osteoarthritis Pain Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Osteoarthritis Pain Consumption and Growth Rate (2017-2022)

    • Table Abbott Laboratories Company Details

    • Table Abbott Laboratories Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Laboratories Osteoarthritis Pain Main Business and Markets Served

    • Table Abbott Laboratories Osteoarthritis Pain Product Portfolio

    • Table Novartis International Company Details

    • Table Novartis International Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis International Osteoarthritis Pain Main Business and Markets Served

    • Table Novartis International Osteoarthritis Pain Product Portfolio

    • Table Afferent Pharmaceuticals Company Details

    • Table Afferent Pharmaceuticals Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

    • Table Afferent Pharmaceuticals Osteoarthritis Pain Main Business and Markets Served

    • Table Afferent Pharmaceuticals Osteoarthritis Pain Product Portfolio

    • Table BioDelivery Sciences International Company Details

    • Table BioDelivery Sciences International Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioDelivery Sciences International Osteoarthritis Pain Main Business and Markets Served

    • Table BioDelivery Sciences International Osteoarthritis Pain Product Portfolio

    • Table AbbVie Company Details

    • Table AbbVie Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie Osteoarthritis Pain Main Business and Markets Served

    • Table AbbVie Osteoarthritis Pain Product Portfolio

    • Table Pfizer Company Details

    • Table Pfizer Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Osteoarthritis Pain Main Business and Markets Served

    • Table Pfizer Osteoarthritis Pain Product Portfolio

    • Table Crystal Genomics Company Details

    • Table Crystal Genomics Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

    • Table Crystal Genomics Osteoarthritis Pain Main Business and Markets Served

    • Table Crystal Genomics Osteoarthritis Pain Product Portfolio

    • Table Cytori Therapeutics Company Details

    • Table Cytori Therapeutics Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cytori Therapeutics Osteoarthritis Pain Main Business and Markets Served

    • Table Cytori Therapeutics Osteoarthritis Pain Product Portfolio

    • Table Johnson & Johnson Company Details

    • Table Johnson & Johnson Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Osteoarthritis Pain Main Business and Markets Served

    • Table Johnson & Johnson Osteoarthritis Pain Product Portfolio

    • Table Abiogen Pharma Company Details

    • Table Abiogen Pharma Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abiogen Pharma Osteoarthritis Pain Main Business and Markets Served

    • Table Abiogen Pharma Osteoarthritis Pain Product Portfolio

    • Table Astellas Pharma Company Details

    • Table Astellas Pharma Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astellas Pharma Osteoarthritis Pain Main Business and Markets Served

    • Table Astellas Pharma Osteoarthritis Pain Product Portfolio

    • Figure Global Oral Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Non-Oral Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pharmacy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Osteoarthritis Pain Consumption Forecast by Country (2022-2028)

    • Table North America Osteoarthritis Pain Consumption Forecast by Country (2022-2028)

    • Figure United States Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Osteoarthritis Pain Consumption Forecast by Country (2022-2028)

    • Figure Germany Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Osteoarthritis Pain Consumption Forecast by Country (2022-2028)

    • Figure China Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Osteoarthritis Pain Consumption Forecast by Country (2022-2028)

    • Figure Brazil Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Osteoarthritis Pain Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Osteoarthritis Pain Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Osteoarthritis Pain Consumption Forecast by Country (2022-2028)

    • Figure Australia Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US